3'-azido-2',3'-dideoxythymidine ( azt ) has been administered to 7 patients with human immunodeficiency virus-associated neurological disease : 3 with dementia , 2 with peripheral neuropathy , 1 with dementia and peripheral neuropathy , and 1 with t-10 paraplegia .
C0043474
azt
C0019693
human immunodeficiency virus